Han SO - Search Results

1

Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade.

Han SO, Li S, Brooks ED, Masat E, Leborgne C, Banugaria S, Bird A, Mingozzi F, Waldmann H, Koeberl D. Han SO, et al. Hum Gene Ther. 2015 Jan;26(1):26-35. doi: 10.1089/hum.2014.115. Hum Gene Ther. 2015. PMID: 25382056 Free PMC article.

2

Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.

Han SO, Li S, Bird A, Koeberl D. Han SO, et al. Hum Gene Ther. 2015 Nov;26(11):743-50. doi: 10.1089/hum.2015.033. Epub 2015 Sep 29. Hum Gene Ther. 2015. PMID: 26417913 Free PMC article.

3

A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.

Han SO, Pope R, Li S, Kishnani PS, Steet R, Koeberl DD. Han SO, et al. Mol Genet Metab. 2016 Feb;117(2):114-9. doi: 10.1016/j.ymgme.2015.09.012. Epub 2015 Oct 3. Mol Genet Metab. 2016. PMID: 26454691 Free PMC article.

4

Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

Han SO, Li S, Koeberl DD. Han SO, et al. Mol Genet Metab. 2016 May;118(1):35-40. doi: 10.1016/j.ymgme.2016.03.006. Epub 2016 Mar 18. Mol Genet Metab. 2016. PMID: 27017193 Free PMC article.

5

Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.

Han SO, Ronzitti G, Arnson B, Leborgne C, Li S, Mingozzi F, Koeberl D. Han SO, et al. Mol Ther Methods Clin Dev. 2017 Jan 11;4:126-136. doi: 10.1016/j.omtm.2016.12.010. eCollection 2017 Mar 17. Mol Ther Methods Clin Dev. 2017. PMID: 28344998 Free PMC article.

6

Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease.

Koeberl DD, Case LE, Smith EC, Walters C, Han SO, Li Y, Chen W, Hornik CP, Huffman KM, Kraus WE, Thurberg BL, Corcoran DL, Bali D, Bursac N, Kishnani PS. Koeberl DD, et al. Among authors: han so. Mol Ther. 2018 Sep 5;26(9):2304-2314. doi: 10.1016/j.ymthe.2018.06.023. Epub 2018 Jul 5. Mol Ther. 2018. PMID: 30025991 Free PMC article. Clinical Trial.

7

Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease.

Han SO, Li S, Everitt JI, Koeberl DD. Han SO, et al. Hum Gene Ther. 2019 Jul;30(7):855-864. doi: 10.1089/hum.2018.197. Epub 2019 Apr 5. Hum Gene Ther. 2019. PMID: 30803275 Free PMC article.

8

Erratum: Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.

Han SO, Ronzitti G, Arnson B, Leborgne C, Li S, Mingozzi F, Koeberl D. Han SO, et al. Mol Ther Methods Clin Dev. 2019 May 1;13:431. doi: 10.1016/j.omtm.2019.04.005. eCollection 2019 Jun 14. Mol Ther Methods Clin Dev. 2019. PMID: 31073535 Free PMC article.

9

Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease.

Han SO, Haynes AC, Li S, Abraham DM, Kishnani PS, Steet R, Koeberl DD. Han SO, et al. Mol Genet Metab. 2020 Feb;129(2):73-79. doi: 10.1016/j.ymgme.2019.10.005. Epub 2019 Oct 17. Mol Genet Metab. 2020. PMID: 31645300 Free PMC article.

10

Improved muscle function in a phase I/II clinical trial of albuterol in Pompe disease.

Koeberl DD, Case LE, Desai A, Smith EC, Walters C, Han SO, Thurberg BL, Young SP, Bali D, Kishnani PS. Koeberl DD, et al. Among authors: han so. Mol Genet Metab. 2020 Feb;129(2):67-72. doi: 10.1016/j.ymgme.2019.12.008. Epub 2019 Dec 10. Mol Genet Metab. 2020. PMID: 31839530 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters